Wednesday, February 10, 2010, 6:08pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Obagi Medical Products, Inc. (OMPI)

At 5:00AM SGT: 10.66 USD   0.00 (0.00%)  
 MORE ON OMPI 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Obagi Medical Products, Inc. (NasdaqNM:OMPI) Delayed quote dataEdit
Last Trade:10.66 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:10.66
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:13.00
Day's Range:N/A - N/A
52wk Range:3.79 - 12.20
Volume:0
Avg Vol (3m):76,917.5
Market Cap:233.58M
P/E (ttm):27.06
EPS (ttm):0.39
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add OMPI to Portfolio   Download Data

 HEADLINES 
•OBAGI MEDICAL PRODUCTS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Jan 12)
•Obagi Medical Products Served with Complaint from ZO Skin Health, Inc.
Business Wire (Fri, Jan 8)
•Dr. Zein Obagi, Preeminent Inventor of Skin Care Products, Challenges Anti-Competitive Practices of Obagi Medical Products, a Company He Founded in 1988 and Later Sold to a Stonington Partners Private Equity Fund
PR Newswire (Fri, Jan 8)
•Obagi Medical Products to Present at the 28th Annual J.P. Morgan Healthcare Conference
Business Wire (Thu, Jan 7)
•Today's 5-Star Movers
at Motley Fool (Thu, Nov 12)
•OBAGI MEDICAL PRODUCTS, INC. Financials
EDGAR Online Financials (Wed, Nov 11)
•OBAGI MEDICAL PRODUCTS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
•OBAGI MEDICAL PRODUCTS INC Earnings Call scheduled for 4:30 pm ET today
CCBN (Fri, Nov 6)
•OBAGI MEDICAL PRODUCTS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
EDGAR Online (Fri, Nov 6)
•In Depth: Healers And Dealers
at Forbes.com (Thu, Oct 15)
More Headlines for OMPI...
 ANALYST 
EPS Est (next year) (Dec-09) :0.54
EPS Est (in 2 years) (Dec-10) :0.70
Avg Rec (current)*:1.9
PEG Ratio:1.42
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Obagi Medical Products, Inc., a specialty pharmaceutical company, develops and markets skincare products in the United States and internationally. The company develops and commercializes prescription-based, topical skin health systems, which enabl...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices